Apex Biotechnology Corp (1733) — Cash Flow Quality Index
Apex Biotechnology Corp (1733) has a Cash Flow Quality Index of 0.18x as of September 2025. Operating cash flow of NT$5.19 Million is below net income of NT$29.21 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 1733 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Apex Biotechnology Corp Cash Flow Quality Index (2002–2024)
Historical Cash Flow Quality Index for Apex Biotechnology Corp across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Apex Biotechnology Corp (1733) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Apex Biotechnology Corp (2002–2024)
Year-by-year earnings quality comparison for Apex Biotechnology Corp. For live market cap and the full company financial profile, see Apex Biotechnology Corp market capitalisation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.15x | NT$328.67 Million | NT$153.13 Million | ▲ +31.3% |
| 2023 | 1.63x | NT$230.39 Million | NT$140.96 Million | ▲ +1125.5% |
| 2022 | 0.13x | NT$26.62 Million | NT$199.57 Million | ▼ -86.3% |
| 2021 | 0.97x | NT$179.87 Million | NT$184.94 Million | ▼ -61.7% |
| 2020 | 2.54x | NT$280.60 Million | NT$110.61 Million | ▼ -10.6% |
| 2019 | 2.84x | NT$462.52 Million | NT$162.94 Million | ▲ +577.8% |
| 2018 | 0.42x | NT$67.57 Million | NT$161.34 Million | ▼ -33.8% |
| 2017 | 0.63x | NT$70.83 Million | NT$111.97 Million | ▼ -88.9% |
| 2016 | 5.72x | NT$298.06 Million | NT$52.09 Million | ▲ +277.3% |
| 2015 | 1.52x | NT$472.15 Million | NT$311.29 Million | ▲ +80.8% |
| 2014 | 0.84x | NT$267.60 Million | NT$318.94 Million | ▼ -26.2% |
| 2013 | 1.14x | NT$484.77 Million | NT$426.38 Million | ▲ +16.5% |
| 2012 | 0.98x | NT$509.67 Million | NT$522.45 Million | ▲ +87.9% |
| 2011 | 0.52x | NT$273.45 Million | NT$526.62 Million | ▼ -49.4% |
| 2010 | 1.03x | NT$465.59 Million | NT$453.95 Million | ▼ -14.4% |
| 2009 | 1.20x | NT$391.29 Million | NT$326.48 Million | ▲ +13.6% |
| 2008 | 1.06x | NT$299.96 Million | NT$284.29 Million | ▲ +16.5% |
| 2007 | 0.91x | NT$364.62 Million | NT$402.53 Million | ▼ -24.2% |
| 2006 | 1.19x | NT$363.71 Million | NT$304.41 Million | ▼ -9.5% |
| 2004 | 1.32x | NT$218.54 Million | NT$165.49 Million | ▼ -29.4% |
| 2003 | 1.87x | NT$302.25 Million | NT$161.60 Million | ▲ +137.0% |
| 2002 | 0.79x | NT$79.49 Million | NT$100.74 Million | — |